Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
24 results
D3.157 - Clinical characteristics and associated factors of persistent asthma in preschool children with wheezing in a tropical region
D3.158 - Dupilumab Response in a Patient with Severe Asthma Refractory to Anti-IL5 Therapy: A Case Report
D3.165 - Phase 1 study of CDX-622, a bispecific antibody targeting TSLP and mast cells via stem cell factor
D3.153 - Add-on Dupilumab therapy significantly reduces severe asthma exacerbations and emergency visits in patients with severe persistent asthma requiring oral corticosteroids for maintenance therapy: our experience in Réunion Island
D3.154 - Trends in Bronchial Asthma Incidence in Crimea: Analysis from 2017-2024 with Age-Specific Insights
D3.155 - Th2–Th17 immune shift following dupilumab therapy
D3.156 - Pulmonary embolism in a young asthma patient
D3.159 - Early Bronchodilator Response in Asthma: When Is Testing Really Necessary?
D3.160 - Study of the allergic sensitization profile in asthmatic patients consulting at ignace deen university hospital, conakry
D3.161 - Efficacy and Safety of Ciclesonide in Achieving Asthma Control: Results of an Observational Multicenter Study in Real-World Clinical Practice
D3.164 - Early and Sustained Effect of Zumilokibart (APG777) in Atopic Dermatitis and Asthma: 16-Week Results from the Phase 2 APEX Study in Moderate-to-Severe AD and a Phase 1b Study in Mild-to-Moderate Asthma
D3.455 - Comparative Characterization of Olfactory Dysfunction in Mouse Models of Eosinophilic Chronic Rhinosinusitis
D3.456 - BEAMER: A multidisciplinary model for disease-agnostic adherence integrating chronic rhinosinusitis: development and prospective study
D3.451 - Long-term follow-up of ASA therapy after desensitization in patients with chronic rhinosinusitis with nasal polyps indicates high rate of treatment discontinuation
D3.454 - Do we still need aspirin desensitization therapy for nasal polyposis?
D3.457 - Does the Way We Ask Matter? Comparing Self- and Interviewer-Administered RQLQ in Allergic Rhinoconjunctivitis
D3.462 - Polysorbate 80 (E433) sensitisation predicts and explains part of the variability of the Chronic Cough and Opposing Defiant Behaviour (ODB) in sensitised children: how the industrialised nutrition impacts the gut-brain axis and favours neuro-inflammation
D3.529 - Altered Virulence of Pseudomonas aeruginosa from Polystyrene-Fed Zophobas atratus Larvae and Immunological Effects of Microplastics on Murine Lungs
- D3.530 - Nonresponsiveness to Hepatitis B Vaccine Is Characterized by Reduced T Stem Cell Memory (TSCM) Cells
- D3.531 - Diverse Infectious Disease Outcomes After SARS CoV 2 Infection in Children and Adolescents: A Nationwide Matched Cohort Study
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download